Showing 1 - 4 results of 4 for search 'Kristian Gaarn Du Jardin', query time: 0.03s Refine Results
  1. 1
    Application of Dermatology Life Quality Index‐Relevant (DLQI‐R) in patients with moderate‐to‐severe plaque psoriasis treated with tildrakizumab

    Application of Dermatology Life Quality Index‐Relevant (DLQI‐R) in patients with moderate‐to‐severe plaque psoriasis treated with tildrakizumab by Philip Laws, Kristian Gaarn Du Jardin

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special interest

    Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adver... by Alexander Egeberg, Denis Jullien, Kristian Gaarn Du Jardin, Diamant Thaçi

    Published 2023-12-01
    Get full text
    Article
  3. 3
    Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents

    Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents by Jessica A. Waller, Sara Holm Nygaard, Yan Li, Kristian Gaarn du Jardin, Joseph A. Tamm, Aicha Abdourahman, Betina Elfving, Alan L. Pehrson, Connie Sánchez, Rasmus Wernersson

    Published 2017-08-01
    Get full text
    Article
  4. 4
    Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks

    Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks by Elke L. M. ter Haar, Juul M. P. A. van den Reek, Kristian Gaarn Du Jardin, Almudena Barbero-Castillo, Elke M. G. J. de Jong, Satish F. K. Lubeek

    Published 2023-10-01
    Get full text
    Article

Search Tools: